Antiviral Therapy
| 短名 | Antivir. Ther. |
| Journal Impact | 1.35 |
| 国际分区 | VIROLOGY(Q4) |
| 期刊索引 | SCI Q4中科院 4 区 |
| ISSN | 1359-6535, 2040-2058 |
| h-index | 93 |
| 国内分区 | 医学(4区)医学传染病学(4区)医学药学(4区)医学病毒学(4区) |
ANTIVIRAL THERAPY（国际抗病毒研究学会的官方出版物）是一份国际同行评审期刊，致力于发表有关抗病毒药物和疫苗的临床开发和使用以及所有病毒性疾病治疗的文章。 ANTIVIRAL THERAPY 是病毒学和传染病领域的领先期刊之一。该期刊内容全面，发表有关抗病毒治疗所有临床方面的文章。它的特色是社论、原创研究论文、特别委托的评论文章、信件和书评。该杂志面向对临床和基础研究感兴趣的医生和专家。
期刊主页投稿网址| 涉及主题 | 医学生物免疫学病毒学遗传学病毒内科学家庭医学人类免疫缺陷病毒（HIV）化学生物化学病毒载量基因抗逆转录病毒疗法病理慢性肝炎病毒性疾病药理学乙型肝炎病毒外科胃肠病学拉米夫定基因型 |
| 出版信息 | 出版商: Sage Publications，出版周期: Bimonthly，期刊类型: journal |
| 基本数据 | 创刊年份: 1996，原创研究文献占比: 76.32%，自引率:0.00%， Gold OA占比: 61.84% |
| 平均审稿周期 | 网友分享经验：偏慢,4-8周 |
| 平均录用比例 | 网友分享经验：较难 |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Comparative efficacy and safety of tenofovir amibufenamide vs tenofovir alafenamide in the initial 48-week treatment of high viral load chronic hepatitis B: A single-centre retrospective study
2024-9-11
Clinical outcomes in patients with mild to moderate coronavirus disease 2019 treated with monoclonal antibody therapy versus an untreated control cohort
2024-7-26
Andrographolide suppresses SARS-CoV-2 infection by downregulating ACE2 expression: A mechanistic study
2024-6-1
<i>In-silico</i> approach to characterize the structure and function of a hypothetical protein of Monkeypox virus exploring Chordopox-A20R domain-containing protein activity
2024-5-27
Assessment of swallowability and acceptability of scored darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) fixed-dose combination (FDC) tablets in HIV-1–infected children aged ≥6 to <12 years, using matching placebo tablets: A randomized study
2024-4-1
Adverse drug reactions attributed to generic substitution of antiretroviral medications among HIV treatment and pre-exposure prophylaxis clients in British Columbia, Canada
2024-2-1
Failure of bamlanivimab with selection of E484K mutation in an allogeneic stem cell transplant recipient with nosocomial SARS-CoV-2 infection
2024-2-1
RVX-208, an inducer of Apolipoprotein A-I, inhibits the particle production of hepatitis B virus through activation of cGAS-STING pathway
2023-12-1
Cross-resistance to entry inhibitors and lenacapavir resistance through Week 52 in study CAPELLA
2023-12-1
Dolutegravir and rilpivirine as successful initial antiretroviral therapy in a treatment-naive patient with HIV-1: A case report
2023-12-1
Waitlist-controlled trial of an online intervention to address mental health among older people living with HIV
2023-11-30
Subacute thyroiditis following COVID-19 vaccination: Case presentation
2023-10-1
Andrographolide inhibits infectious bronchitis virus-induced apoptosis, pyroptosis, and inflammation
2023-10-1
HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective
2023-9-25
Computer-assisted drug discovery of potential natural inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase through a multi-phase <i>in silico</i> approach
2023-9-5
Retrospective chart review of transplant recipients with cytomegalovirus infection who received maribavir in the Phase 3 SOLSTICE trial: Data at 52 weeks post-maribavir treatment initiation
2023-9-1
Hepatitis C virus/Hepatitis B virus coinfection: Current prospectives
2023-7-25
Fanconi syndrome, diabetes insipidus, and acute kidney injury due to tenofovir disoproxil fumarate: A case report
2023-6-1
Feminizing hormone therapy in a Canadian cohort of transgender women with and without HIV
2023-6-1
Letter to the editor on use of antibodies from convalescent sera in the treatment of moderate and severe Covid-19 infection
2023-6-1
Genotypic and phenotypic characterization of influenza A viral variants in study participants treated with pimodivir in the phase 2b TOPAZ study
2023-5-24
The evolution of clinical study design in heavily treatment-experienced persons with HIV: A critical review
2023-5-22
A single, oral dose of the TLR7 agonist JNJ-64794964 induces transcriptomic and phenotypic changes in peripheral immune cells in healthy adults
2023-5-18
Abacavir safety and effectiveness in young infants with HIV in South African observational cohorts
2023-4-1
Lipid and glucose abnormalities and associated factors among children living with HIV in Asia
2023-4-1
Treatment-related early discontinuations and adverse events among newly diagnosed people living with HIV initiating integrase inhibitors in a real-world setting
2023-3-10
Case report and literature review: A hiccup patient developed encephalitis and duodenal perforation
2023-3-2
Efficacy, safety and tolerability of Biktarvy in HIV-1 infection: A scoping review
2023-2-1
Inhibition of chikungunya virus replication by N-ω-Chloroacetyl-L-Ornithine in C6/36, Vero cells and human fibroblast BJ
2023-2-1
Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participants
2023-1-24
Pharmacokinetics of zanamivir in critically ill patients undergoing continuous venovenous hemofiltration
2023-1-7
A favipiravir-induced angioedema and urticaria in a COVID-19 patient
2022-12-1
Understanding the effect of direct-acting antiviral therapy on weight in patients with chronic hepatitis C
2022-12-1
Letermovir use to treat complex cytomegalovirus reactivations in two heart transplant recipients
2022-11-18
EDP-514 in healthy subjects and nucleos(t)ide reverse transcriptase inhibitor-suppressed patients with chronic hepatitis B
2022-11-15
Preface: Special Collection Commemorating John C. Martin
2022-10-1
Antiretroviral therapy adherence patterns, virological suppression, and emergence of drug resistance: A nested case–control study from Uganda and South Africa
2022-10-1
A Phase 1 randomized study of GSK3732394, an investigational long-acting biologic treatment regimen for HIV-1 infection
2022-10-1
Antiretroviral therapy achieved metabolic complete remission of hepatic AIDS related Epstein-Barr virus-associated smooth muscle tumor
2022-9-13
Pharmacokinetic interaction between raltegravir and rifampicin in an infant with HIV exposed to active TB: a case report
2022-8-1
Progress in the quality of care for newly diagnosed people with HIV in Spain (2004–2019)
2022-6-1
Resistance levels to non-nucleoside reverse transcriptase inhibitors among pregnant women with recent HIV infection in Malawi
2022-6-1
JNJ-73763989 pharmacokinetics and safety: Liver-targeted siRNAs against hepatitis B virus, in Japanese and non-Japanese healthy adults, and combined with JNJ-56136379 and a nucleos(t)ide analogue in patients with chronic hepatitis B
2022-6-1
Socioeconomic status largely explains integrase inhibitors-related body composition differences in chronically infected men living with HIV
2022-6-1
The renal-bone axis in older people living with HIV on stable antiretroviral therapy: A sub-analysis of the GS-US-104-0423 study
2022-6-1
Outcomes of etravirine-based antiretroviral treatment in treatment-experienced children and adolescents living with HIV in Europe and Thailand
2022-6-1
Acquired HIV drug resistance among adults living with HIV receiving first-line antiretroviral therapy in Rwanda: A cross-sectional nationally representative survey
2022-5-20
Changes in blood lipids in patients with chronic hepatitis B after 48 weeks of tenofovir alafenamide treatment: A prospective real-world clinical study
2022-4-1
Case study of hepatitis C virus control in Egypt: impact of access program
2022-4-1
The role of tenofovir disoproxil fumarate for preventing vertical transmission of hepatitis B
2022-4-1
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远